Procter & Gamble Company (The) (PG)

Procter & Gamble's dominant portfolio of household and personal care brands provides a durable, cash-generative defensive moat, supported by consistent EPS execution (4-for-4 beat rate) and a constructive analyst consensus with zero Sell ratings. However, a -15.5% YoY earnings decline and a PEG ratio of 4.14 signal that near-term earnings power is under pressure — pricing tailwinds have faded while volume recovery remains elusive. The primary risk is that a prolonged period of earnings contraction erodes the premium valuation multiple the market has historically awarded PG.

• Volume recovery in key categories (Fabric & Home Care, Baby/Feminine) as consumer trade-down pressures ease in H2 FY2025, with quarterly unit growth returning to positive territory
• Margin expansion from moderating input cost inflation and ongoing productivity programs, which could drive a meaningful EPS rebound and reverse the -15.5% YoY decline as early as Q1 FY2026
• Emerging market acceleration — particularly in Asia Pacific and Latin America — where PG is investing in premiumization and local brand penetration, providing an incremental revenue growth vector beyond the current +1.5% pace

Compass screens thousands of stocks every morning and hands you a short list of high-conviction picks — scored, explained, and re-ranked to your risk profile.

Compass pre-filters thousands of U.S. equities by fundamentals, then an AI analyst scores each finalist 1–5 across six measures — spanning valuation, growth, analyst sentiment, and management quality — into one composite score, refreshed every market morning. Browse all covered stocks →